Perrigo Moves In On Major Generic Firms With Agis Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's acquisition of Israeli generic drug firm Agis Pharmaceuticals will put the combined entity's annualized sales over the $1 bil. mark and in the same league with major Rx generic drug players
You may also be interested in...
Perrigo appointment
Judy Brown, Senior VP and Corporate Controller for Perrigo, will assume her new role as the company's CFO and Chief Accounting Officer July 1, the Allegan, Mich.-based firm announces March 2. Brown will replace current CFO Douglas Schrank, who has been at Perrigo for six years. Brown is a certified public accountant who previously worked for Whirlpool and Ernst & Young. In her current role, Brown has helped lead the company through its acquisition of Agis Industries, which was completed in March (1"The Tan Sheet" Nov. 22, 2004, p. 6)...
Perrigo appointment
Judy Brown, Senior VP and Corporate Controller for Perrigo, will assume her new role as the company's CFO and Chief Accounting Officer July 1, the Allegan, Mich.-based firm announces March 2. Brown will replace current CFO Douglas Schrank, who has been at Perrigo for six years. Brown is a certified public accountant who previously worked for Whirlpool and Ernst & Young. In her current role, Brown has helped lead the company through its acquisition of Agis Industries, which was completed in March (1"The Tan Sheet" Nov. 22, 2004, p. 6)...
Perrigo appointment
Judy Brown, Senior VP and Corporate Controller for Perrigo, will assume her new role as the company's CFO and Chief Accounting Officer July 1, the Allegan, Mich.-based firm announces March 2. Brown will replace current CFO Douglas Schrank, who has been at Perrigo for six years. Brown is a certified public accountant who previously worked for Whirlpool and Ernst & Young. In her current role, Brown has helped lead the company through its acquisition of Agis Industries, which was completed in March (1"The Tan Sheet" Nov. 22, 2004, p. 6)...